Kirby John J., Interim CFO of Verrica Pharmaceuticals Inc. ($VRCA), made one open market purchase of company shares in the last 365 days, totaling about $15,000. His most recent buy occurred on November 25, 2025. This purchase ranks 4032nd among 4983 individual insiders in our database, where the average buy amounts to $1.46 million across 3.29 transactions. Kirby John J. reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 23, 2025 | Verrica Pharmaceuticals Inc. | $VRCA | Kirby John J. | Interim CFO | A | Common Stock | 10000 | $0.00 | 18,962.0000 | 9,490,035 | 111.58% | 0.11% |
| Nov. 25, 2025 | Verrica Pharmaceuticals Inc. | $VRCA | Kirby John J. | Interim CFO | P | Common Stock | 3536 | $4.24 | 8,962.0000 | 9,490,035 | 65.17% | 0.04% |
| Nov. 25, 2025 | Verrica Pharmaceuticals Inc. | $VRCA | Kirby John J. | Interim CFO | P | Series C Warrant (right to buy) | 884 | $0.00 | 884.0000 | 9,490,035 | 9999.99% | 0.01% |
| Nov. 6, 2024 | Verrica Pharmaceuticals Inc. | $VRCA | Kirby John J. | Interim CFO | A | Common Stock | 54267 | $0.00 | 54,267.0000 | 0 | 9999.99% | 0.00% |